ORKA
Financials
- Market Capitalization 6.14 B
- Employee 68
- Founded 2024
- CEO N/A
- Website www.orukatx.com
- Headquarter Delaware, United States
- FIGI BBG000BWNN28
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 441 |  BIIB Biogen Inc. - Common Stock | 217.40 USD | -1.85% | -0.30% | +3.11% | +64.08% | 32.12 B USD | ||
| 1145 |  CGON CG Oncology, Inc. - Common stock | 76.41 USD | -3.29% | -2.13% | +4.23% | +75.41% | 6.77 B USD | ||
| 1481 |  MANE Veradermics, Incorporated Common Stock | 101.22 USD | -0.36% | -4.74% | -9.63% | +206.73% | 4.23 B USD | ||
| 1586 |  OGN Organon & Co. Common Stock | 13.77 USD | +0.07% | +0.22% | +1.85% | +89.67% | 3.62 B USD |
Frequently asked questions about Oruka Therapeutics, Inc. Common Stock
What is the Oruka Therapeutics, Inc. Common Stock stock price today?
The current price of Oruka Therapeutics, Inc. Common Stock (ORKA) is 92.69. Over the past 24 hours, the stock has changed by -3.99%. Follow the ORKA chart for real-time price dynamics.
What is the stock ticker of Oruka Therapeutics, Inc. Common Stock?
Oruka Therapeutics, Inc. Common Stock trades under the ticker ORKA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Oruka Therapeutics, Inc. Common Stock stock going up?
ORKA has changed by -14.18% over the last week, +1.96% over the last month, and +189.02% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Oruka Therapeutics, Inc. Common Stock?
Oruka Therapeutics, Inc. Common Stock currently has a market capitalization of 6.14 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Oruka Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Oruka Therapeutics, Inc. Common Stock reported earnings of -0.55 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Oruka Therapeutics, Inc. Common Stock net income for the last quarter?
Oruka Therapeutics, Inc. Common Stock reported net income of -41.21 M for the last quarter. The previous quarter showed -31.82 M, which means net income changed by -29.50%.
How many employees does Oruka Therapeutics, Inc. Common Stock have?
As of the latest available data, Oruka Therapeutics, Inc. Common Stock has 68 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Oruka Therapeutics, Inc. Common Stock stock?
You can buy Oruka Therapeutics, Inc. Common Stock (ORKA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Oruka Therapeutics, Inc. Common Stock stock?
Investing in Oruka Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ORKA chart and related analysis on metatrader.com as part of your research.